Ads
related to: renal cell carcinoma treatment- How This Treatment Works
Learn More About How This
FDA-Approved Treatment Works.
- FAQs
Find FAQs For This Treatment
Option On The Official Patient Site
- Patient Resources
Find Patient Resources
On The Official Site.
- Clinical Trial Info
Review Clinical Trial Results For
This FDA-Approved Treatment Option.
- How This Treatment Works
Search results
Director Julie Smith Sells 27,280 Shares of Exelixis Inc (EXEL)
GuruFocus.com via Yahoo Finance· 25 minutes agoExelixis Inc is a biotechnology company focused on the discovery, development, and commercialization...
Eisai Showcases Oncology Portfolio and Pipeline at ASCO 2024
FOX 23 News Albany· 19 hours agoNotable data include an oral presentation on biomarker analyses from the pivotal Phase 3 CLEAR (Study 307)/KEYNOTE-581 trial (NCT02811861), which evaluated lenvatinib (LENVIMA®), the orally ...
Cure Genetics Announced Promising Safety and Efficacy Data of CAR-NKT Product CGC729 for RCC at...
WKBN 27 Youngstown· 16 hours agoOn May 10, 2024, Cure Genetics announced the safety and efficacy data of their CAR-NKT product, CGC729, for patients with relapsed and refractory metastatic renal
Kidney Cancer Immunotherapy Response Linked to Signature Reflecting HLA, Tumor Immune Activity
GenomeWeb News· 3 days agoResearchers found an immune checkpoint blockade response signature in renal cell carcinoma that reflects tumor immune activity influenced by human leukocyte antigen features.
Ipilimumab, a Pioneer Breakthrough in Cancer Treatment
Forbes· 4 days agoIn 2011, the first in a new generation of anticancer drugs called checkpoint inhibitors was...
Rutgers Cancer Institute and RWJBarnabas Health Se | Newswise
Newswise· 1 day agoClinicians and scientists from Rutgers Cancer Institute and RWJBarnabas Health will lead sessions...
Tumor mutations may not predict response to immunotherapy, study finds
Medical Xpress· 16 hours agoThe findings, published in Nature Cancer, upend long-held conventional wisdom and could lead to more effective ways of deciding which patients will benefit most from this type of treatment ...
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 9 hours agoSALT LAKE CITY, May 23, 2024 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, and its collaborators will share data from seven studies at the 2024 ASCO Annual Meeting. Three studies
Biomica Presents Positive Clinical Data Update from Ongoing Phase 1 Trial of Microbiome-Based...
WTNH-TV New Haven· 16 hours agoData will be showcased at the 2024 American Society of Clinical Oncology (ASCO) annual meeting....
Get Ready for ASCO 2024 Annual Meeting | Newswise
Newswise· 2 days agoASCO, the largest event in cancer research, is approaching on May 31st. This year's meeting promises to be particularly groundbreaking, with new findings a